Dr. Katja Geßner

Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie

From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy (2024) Cuba L, Dürr P, Dörje F, Fromm M, Schlichtig K Journal article Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center (2023) Cuba L, Schlichtig K, Dürr P, Inwald EC, Fromm M, Dörje F Journal article Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial (2022) Dürr P, Meier F, Schlichtig K, Schramm A, Schötz L, Fromm M, Dörje F Journal article Drug Therapy Safety with new oral Antitumor Agents for the Therapy of Prostate and Renal Cell Carcinoma: Findings from the AMBORA Study (2022) Cuba L, Schlichtig K, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Conference contribution AMBORA Study/AMTS Competence and Advice Center for oral Tumor Therapy (2022) Schlichtig K Conference contribution New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial (2022) Schlichtig K, Cuba L, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Journal article Development and validation of an LC-MS method for drug exposure measurement of 57 oral antitumor drugs in human plasma (2022) Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V Conference contribution A LC-HRMS method for drug exposure measurement of 57 oral anticancer drugs in human plasma (2022) Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V Conference contribution Ökonomische Aspekte bei der Versorgung von Patient*innen mit neuen oralen Tumortherapeutika: Erkenntnisse aus der AMBORA-Studie (2022) Dürr P, Schlichtig K, Krebs S, Schramm A, Schötz L, Fromm M, Dörje F Journal article An easily expandable multi-drug LC-MS assay for the simultaneous quantification of 57 oral antitumor drugs in human plasma (2021) Kehl N, Schlichtig K, Dürr P, Bellut L, Dörje F, Fietkau R, Pavel ME, et al. Journal article